You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 94 23 486 or email: subscribe@krixos.com |
|
Most viewed
- 1. SPPORT analysis highlights potential role of genetic testing in identifying prostate cancer patients who may benefit most from hormone therapy
- 2. RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results
- 3. Chinese Medical Journal study reveals gallic acid inhibits prostate cancer progression via the NF-κB/KLF7/L1CAM Axis
- 4. PSMA PET/CT-targeted biopsy improves detection of clinically significant prostate cancer
- 5. Cancer trial drug may work differently than scientists believed, raising concerns for clinical research
- 6. Visual EXPO by BRANDED SHORTS Debuts in Tokyo, Celebrating Excellence in Branded Storytelling
- 7. Tigerlily Foundation's Pajama Glam Empowers Girls and Families Through Health Literacy, Self-Advocacy and Connection
- 8. Prioritizing women's health ‘a shared responsibility'
- 9. After years of calls for data, study confirms Black Canadians face higher risk of maternal complications
- 10. Alliance Foundation trials and Natera announce AFT-70 navigate: A global, randomized, phase iii trial evaluating genentech's oral Selective Estrogen Receptor Degrader (SERD) with SignateraTM MRD-Guided CDK4/6 inhibitor therapy in ER+/HER2− breast canc
Last updated at 16:54 GMT
